UTHRHealthcareLarge-Cap

UNITED THERAPEUTICS Corp Insider Trading Activity

Every SEC Form 4 insider transaction reported for UNITED THERAPEUTICS Corp (UTHR), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are UTHR insiders buying or selling?

UNITED THERAPEUTICS Corp insiders reported 1 open-market buys ($529.16) and 663 sells ($2.2B) across 664 Form 4 filings — a net selling position of $2.2B.

Source: SEC EDGAR Form 4

Key Statistics (as of Sep 2, 2026)

Total Form 4 filings
664
SEC EDGAR
Insider filers
15
Insider buys (1)
$529.16
Insider sells (663)
$2.2B

Insider sentiment

Net selling

Net insider flow of $2.2B in net selling.

Recent UTHR insider transactions

DateInsiderRoleTypeSharesPriceValue
Sep 2, 2026Martine A RothblattChairperson & CEOSale9.5K$514.09$4.9M
Sep 1, 2026Martine A RothblattChairperson & CEOSale9.5K$511.09$4.9M
Aug 31, 2026Martine A RothblattChairperson & CEOSale9.5K$517.51$4.9M
Aug 28, 2026Martine A RothblattChairperson & CEOSale9.5K$522.57$5.0M
Aug 27, 2026Martine A RothblattChairperson & CEOSale9.5K$517.28$4.9M
Aug 26, 2026Martine A RothblattChairperson & CEOSale9.5K$517.71$4.9M
Aug 25, 2026Martine A RothblattChairperson & CEOSale9.5K$511.97$4.9M
Aug 24, 2026Martine A RothblattChairperson & CEOSale9.5K$518.39$4.9M
Aug 21, 2026Martine A RothblattChairperson & CEOSale9.5K$521.02$4.9M
Aug 21, 2026Paul A MahonEVP & GENERAL COUNSELSale8.3K$523.14$4.3M
Aug 20, 2026Martine A RothblattChairperson & CEOSale9.5K$526.96$5.0M
Aug 19, 2026Martine A RothblattChairperson & CEOSale9.5K$515.60$4.9M
Aug 18, 2026Martine A RothblattChairperson & CEOSale9.5K$506.59$4.8M
Aug 17, 2026Martine A RothblattChairperson & CEOSale9.5K$498.91$4.7M
Aug 14, 2026Martine A RothblattChairperson & CEOSale9.5K$504.24$4.8M
Aug 13, 2026Martine A RothblattChairperson & CEOSale9.5K$515.03$4.9M
Aug 12, 2026Martine A RothblattChairperson & CEOSale9.5K$522.87$5.0M
Aug 11, 2026Martine A RothblattChairperson & CEOSale9.5K$530.11$5.0M
Aug 10, 2026Martine A RothblattChairperson & CEOSale9.5K$531.38$5.0M
Aug 7, 2026Martine A RothblattChairperson & CEOSale9.5K$525.36$5.0M
Aug 6, 2026Paul A MahonEVP & GENERAL COUNSELSale8.3K$517.05$4.3M
Aug 6, 2026Martine A RothblattChairperson & CEOSale9.5K$518.74$4.9M
Aug 5, 2026Martine A RothblattChairperson & CEOSale9.5K$517.09$4.9M
Aug 4, 2026Martine A RothblattChairperson & CEOSale9.5K$516.06$4.9M
Aug 3, 2026Martine A RothblattChairperson & CEOSale9.5K$518.96$4.9M

Showing the 25 most recent of 664 Form 4 filings for UNITED THERAPEUTICS Corp.

Most active UTHR insiders

  • Martine A Rothblatt343 filings
  • Paul A Mahon100 filings
  • James Edgemond49 filings
  • Michael Benkowitz48 filings
  • Christopher Causey24 filings

Ask anything about UTHR insider activity

Use Trabud's AI agent to query UNITED THERAPEUTICS Corp's Form 4 history in plain English — "Show me UTHR CEO purchases this year" or compare it against any other ticker.

Open the AI agent

UTHR insider trading FAQ

Are UNITED THERAPEUTICS Corp insiders buying or selling?

Across 664 SEC Form 4 filings, UNITED THERAPEUTICS Corp (UTHR) insiders reported 1 open-market purchases totaling $529.16 and 663 sales totaling $2.2B. That is a net selling position of $2.2B.

How many insiders trade UTHR stock?

15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for UNITED THERAPEUTICS Corp. The most recent filing was accepted on Sep 2, 2026.

Where does Trabud get UTHR insider trading data?

All UTHR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content